Grant: Gieskes-Strijbis Fonds
Project name: NeuroTech (Novel Patient-Based Molecular and Cellular FTD Models for Innovative Treatment)
Researchers: -Dr. Dimphna Meijer is assistant professor and group leader of the Molecular and Cellular Neurobiology research group at TU Delft.
-Dr. Harro Seelaar is a neurologist and assistant professor at the Department of Neurology and Alzheimer's Center Erasmus MC.
-Dr. Daan Brinks, assistant professor and group leader at Imaging Physics (TUD), expert in electrophysiology of neuronal cells and tissues, innovative voltage microscopy.
-Dr. Tiago Costa, assistant professor and group leader at the Department of Microelectronics (TUD), expert in ultrasonic microsystems.
-Dr. Alina Rwei, assistant professor and group leader at Chemical Engineering (TUD), expert in precision medicine delivery and wearable electronics.
-Dr. Maren Wehrle, associate professor of Practical Philosophy (EUR), expert in the phenomenology/experience of aging.
-Dr. Geeske van Woerden, associate professor and group leader at the departments of Neuroscience and Clinical Genetics (EMC), expert in human genetic disorders and mouse models.
Timeline: 2023 - 2027
Our brains are constantly changing. Our Convergence team from Delft University of Technology, Erasmus University Rotterdam and the Erasmus Medical Center consists of brain scientists, engineers, doctors and philosophers who aim to jointly develop an integrated model of the changing brain. This knowledge is used to develop an innovative, life-course-specific approach to brain diseases. A select core group of our Convergence team focuses on (premature) age-related diseases, in particular fronto-temporal dementia (FTD), for which no adequate scale models are available. We will develop new biological scale models of FTD to gain a better understanding of the disease and to find clues to slow down and stop the disease.